Showing results (181-190 of 290) with videos related to

Sort By:
Pageof 29
BMC Cancer|May 17, 2007
BRIP1 (BACH1) variants and familial breast cancer risk: a case-control studyBernd Frank, Kari Hemminki, Alfons Meindl, et al.
Carcinogenesis|October 28, 2005
Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variantBernd Frank, Kari Hemminki, Barbara Wappenschmidt, et al.
Cerebrovascular Diseases (Basel, Switzerland)|July 3, 2013
Temporal profile of matrix metalloproteinases and their inhibitors in a human endothelial cell culture model of cerebral ischemiaBjörn Reuter, Claus Rodemer, Saskia Grudzenski, et al.
Hamostaseologie|October 26, 2022
Platelets and Sera from Donors of Convalescent Plasma after Mild COVID-19 Show No Procoagulant PhenotypeGünalp Uzun, Anurag Singh, Wissam Abou-Khalel, et al.
Oncotarget|October 6, 2017
HYAL2 methylation in peripheral blood as a potential marker for the detection of pancreatic cancer: a case control studySarah Schott, Rongxi Yang, Sarah Stöcker, et al.
International Journal of Cancer|December 15, 2005
Association of the ARLTS1 Cys148Arg variant with familial breast cancer riskBernd Frank, Kari Hemminki, Alfons Meindl, et al.
Nutrients|September 6, 2019
Thrombomodulin and Thrombopoietin, Two Biomarkers of Hemostasis, Are Positively Associated with Adherence to the World Cancer Research Fund/American Institute for Cancer Research Recommendations for Cancer Prevention in a Population-Based Cross-Sectional StudyMirja Grafetstätter, Laura Pletsch-Borba, Disorn Sookthai, et al.
Cytotherapy|June 9, 2024
Inter- and Intra-donor variability in bone marrow-derived mesenchymal stromal cells: implications for clinical applicationsAlpa Trivedi, Maximillian Lin, Byron Miyazawa, et al.
Carcinogenesis|November 20, 2004
The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer riskBernd Frank, Kari Hemminki, Michael Wirtenberger, et al.
Frontiers in Toxicology|August 27, 2025
Fetal bovine serum: how to leave it behind in the pursuit of more reliable scienceTilo Weber, Atena Malakpour-Permlid, Aline Chary, et al.
Pageof 29